Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: Molecules. 2017 Jun 1;22(6):E917. doi: 10.3390/molecules22060917

Figure 4.

Figure 4

Structures of adenosine ligands which were evaluated in clinical trials. The therapeutic areas represented a range from cardiovascular to neurodegenerative diseases such as Parkinson’s disease [25]. For a more in-depth review, the reader is referred to a recent review [3].